Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA, Hims and peptide

Digest more
Top News
Overview
 · 5h · on MSN
Hims & Hers stock pops on FDA panel’s peptide recommendation
The company gets most of its revenue from branded GLP-1s and other products. Most analysts see the stock fully valued.

Continue reading

 · 3h
Hims & Hers Health (HIMS) Gains On FDA Panel News, Is The Valuation Gap Still Wide?
 · 16h
Hims & Hers stands to gain if the FDA loosens restrictions on peptides
 · 8h
FDA panel votes to ease restrictions on an unregulated peptide BPC-157
The FDA voted by committee to ease restrictions on BPC-157, a popular peptide among influencers who market peptides as an effective treatment for weight loss, immunity and skin health.

Continue reading

 · 1d
FDA panel to review popular peptides amid persistent consumer appetite
 · 12h
FDA Advisory Committee to Review Peptide Restrictions Underway
9d

Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $35.15, moving +2.24% from the previous trading session.
17d

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.
Seeking Alpha
4mon

Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track

Hims & Hers Health, Inc. surges after securing a partnership with Novo Nordisk, resolving legal and regulatory overhangs tied to compounded GLP-1s. HIMS's long-term platform thesis centers on becoming the go-to digital health platform, leveraging ...
Morningstar
1mon

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

From connected fitness and cycle tracking to meal delivery and glucose monitoring, Hims & Hers subscribers now have ten ways to support their whole-body health Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced ...
Business Wire
4mon

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health. This new initiative ...
Seeking Alpha
5mon

Hims & Hers to buy Australian digital health firm Eucalyptus for over $1B

Hims & Hers Health (HIMS) added ~7% in the premarket on Thursday after announcing an agreement to acquire Eucalyptus, an Australian digital health provider, in a cash and stock transaction valued at up to $1.15B. With an annual revenue run rate exceeding $ ...
11h

Telehealth Firms Urge FDA to Legalize Peptides

Telehealth companies including Hims & Hers Health Inc. and Noom Inc. urged a panel of experts to recommend legalizing a handful of popular peptides, while calling for more oversight and the creation of a system to report side effects.
ncnewsonline.com
6d

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9,
  • Privacy
  • Terms